Article info

Download PDFPDF

Biologics in inflammatory disease: infliximab associated risk of lymphoma development
Free
  1. Correspondence to:
    Dr P Went
    Institute of Pathology, University of Basel, Schönbeinstrasse 40, CH-4031 Basel, Switzerland; pwentuhbs.ch
View Full Text

Citation

Bucher C, Degen L, Dirnhofer S, et al
Biologics in inflammatory disease: infliximab associated risk of lymphoma development

Publication history

  • First published April 14, 2005.
Online issue publication 
April 14, 2005

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.